Immuno-polymeric nanoparticles by Diels-Alder chemistry.
暂无分享,去创建一个
[1] Ho Sup Yoon,et al. Co-delivery of drugs and DNA from cationic core–shell nanoparticles self-assembled from a biodegradable copolymer , 2006, Nature materials.
[2] Thommey P. Thomas,et al. HER2 specific tumor targeting with dendrimer conjugated anti-HER2 mAb. , 2006, Bioconjugate chemistry.
[3] Vanessa Schmidt,et al. Diblock copolymer micellar nanoparticles decorated with annexin-A5 proteins. , 2006, Journal of the American Chemical Society.
[4] C. Allen,et al. Epidermal growth factor-conjugated poly(ethylene glycol)-block- poly(delta-valerolactone) copolymer micelles for targeted delivery of chemotherapeutics. , 2006, Bioconjugate chemistry.
[5] Marie-Hélène Dufresne,et al. Block copolymer micelles: preparation, characterization and application in drug delivery. , 2005, Journal of controlled release : official journal of the Controlled Release Society.
[6] R. Häner,et al. Synthesis and bioconjugation of diene-modified oligonucleotides. , 2005, Bioconjugate chemistry.
[7] Kazunori Kataoka,et al. Smart polymeric micelles for gene and drug delivery. , 2005, Drug discovery today. Technologies.
[8] V. Torchilin. Recent advances with liposomes as pharmaceutical carriers , 2005, Nature Reviews Drug Discovery.
[9] You Han Bae,et al. Super pH-sensitive multifunctional polymeric micelle. , 2005, Nano letters.
[10] Hua Ai,et al. cRGD-functionalized polymer micelles for targeted doxorubicin delivery. , 2004, Angewandte Chemie.
[11] R. Kumar,et al. Supramolecular assemblies based on copolymers of PEG600 and functionalized aromatic diesters for drug delivery applications. , 2004, Journal of the American Chemical Society.
[12] Ick Chan Kwon,et al. Physicochemical Characteristics of Self-Assembled Nanoparticles Based on Glycol Chitosan Bearing 5β-Cholanic Acid , 2003 .
[13] S. Otto,et al. Hydrophobic interactions and chemical reactivity. , 2003, Organic & biomolecular chemistry.
[14] M. Bally,et al. Targeting of antibody conjugated, phosphatidylserine-containing liposomes to vascular cell adhesion molecule 1 for controlled thrombogenesis. , 2003, Biochimica et biophysica acta.
[15] Vladimir P. Torchilin,et al. Immunomicelles: Targeted pharmaceutical carriers for poorly soluble drugs , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[16] T. Allen. Ligand-targeted therapeutics in anticancer therapy , 2002, Nature Reviews Cancer.
[17] K. Kono,et al. Targetability and intracellular delivery of anti-BCG antibody-modified, pH-sensitive fusogenic immunoliposomes to tumor cells. , 2002, International journal of pharmaceutics.
[18] J. Carter,et al. Diels--Alder bioconjugation of diene-modified oligonucleotides. , 2001, The Journal of organic chemistry.
[19] S M Moghimi,et al. Long-circulating and target-specific nanoparticles: theory to practice. , 2001, Pharmacological reviews.
[20] V. Torchilin,et al. p-Nitrophenylcarbonyl-PEG-PE-liposomes: fast and simple attachment of specific ligands, including monoclonal antibodies, to distal ends of PEG chains via p-nitrophenylcarbonyl groups. , 2001, Biochimica et biophysica acta.
[21] G. Martiny-Baron,et al. Targeting of endothelial KDR receptors with 3G2 immunoliposomes in vitro. , 2000, Biochimica et biophysica acta.
[22] M. Mrksich,et al. Diels-Alder Reaction for the Selective Immobilization of Protein to Electroactive Self-Assembled Monolayers , 1999 .
[23] T. Tarasow,et al. RNA-catalysed carbon–carbon bond formation , 1997, Nature.
[24] M S Newman,et al. Immunogenicity and pharmacokinetic attributes of poly(ethylene glycol)-grafted immunoliposomes. , 1997, Biochimica et biophysica acta.
[25] T. Allen,et al. A new strategy for attachment of antibodies to sterically stabilized liposomes resulting in efficient targeting to cancer cells. , 1995, Biochimica et biophysica acta.
[26] A. Ashkenazi,et al. Conjugation of soluble CD4 without loss of biological activity via a novel carbohydrate-directed cross-linking reagent. , 1992, The Journal of biological chemistry.
[27] W Godolphin,et al. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. , 1989, Science.
[28] Ronald Breslow,et al. Hydrophobic acceleration of Diels-Alder reactions , 1980 .
[29] R. Gurny,et al. Biodegradable nanoparticles for direct or two-step tumor immunotargeting. , 2006, Bioconjugate chemistry.
[30] H. Waldmann,et al. Diels-Alder ligation and surface immobilization of proteins. , 2005, Angewandte Chemie.
[31] G. Hermanson. Antibody Modification and Conjugation , 1996 .